A novel standardized composition, method of manufacture and use in the resolution of RNA virus infection
Details for Australian Patent Application No. 2009347566 (hide)
International Classifications
Event Publications
3 March 2011 Application Open to Public Inspection
Published as AU-B-2009347566
3 March 2011 PCT application entered the National Phase
PCT publication WO2011/018793 Priority application(s): WO2011/018793
31 May 2012 Application Accepted
Published as AU-B-2009347566
11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
18 October 2012 Section 223 Application Allowed
Indus Biotech Private Limited The time in which to pay the acceptance fee has been extended to 31 Oct 2012 . Address for service in Australia - Monks IP PO Box 164 Blackheath NSW 2785
25 October 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009347567-Syringe-attached topical anesthetic dispenser
2009347565-Use of methylation status of MINT loci as marker for rectal cancer
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser
